The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer
Open accessAbstract
The effect of anastrozole ('Arimidex', ZD1033), a new, selective, non-steroidal aromatase inhibitor on in vivo aromatisation and plasma oestrogen levels was evaluated in post-menopausal women with breast cancer. Twelve patients progressing after treatment with tamoxifen were randomised to receive anastrozole 1 mg or 10 mg once daily for a 28 day period in a double-blinded crossover design. In vivo aromatisation and plasma oestrogen levels were determined before commencing treatment and at the end of each 4-week period. Treatment with anastrozole 1 and 10 mg reduced the percentage aromatisation from 2.25% to 0.074% and 0.043% (mean suppression of 96.7% and 98.1% from baseline) and suppressed plasma levels of oestrone, oestradiol and oestrone sulphate by > or = 86.5%, > or = 83.5% and > or = 93.5% respectively, irrespective of dose. Notably, several patients had their oestrone and oestradiol values suppressed beneath the sensitivity limit of the assays. In conclusion, anastrozole was found to be highly effective in inhibiting in vivo aromatisation with no difference in efficacy between the two drug doses. Contrary to previous studies on other aromatase inhibitors, this study revealed an internal consistency between the percentage aromatase inhibition and suppression of plasma oestrone sulphate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Source of Estrogen Production in Postmenopausal Women1
GRODIN, J. M., SIITERI, P. K., & MACDONALD, P. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-2-207 · Cited by 959
SANTEN, R. J., SANTNER, S., DAVIS, B., VELDHUIS, J., SAMOJLIK, E., & RUBY, E. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-6-1257 · Cited by 342
CASH, R., BROUGH, A. J., COHEN, M. N. P., & SATOH, P. S. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-9-1239 · Cited by 260
Arimidex�: A potent and selective fourth-generation aromatase inhibitor
Plourde, P. V., Dyroff, M., & Dukes, M. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682745 · Cited by 258
Dowsett, M., Jones, A. L., Johnston, S. R. D., Jacobs, S., Trunet, P. F., & Smith, I. E. (1995) · PubMed · Cited by 258
Self-citationDowsett, M., Goss, P. E., Powles, T., Hutchinson, G., Brodie, A. M., Jeffcoate, S. L., & Coombes, R. C. (1987) · PubMed · Cited by 238
Self-citation4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
Coombes, R. C., Dowsett, M., Goss, P., Gazet, J.-C., & Brodie, A. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92795-8 · Cited by 235
Self-citationEvans, T. R. J., di Salle, E., Ornati, G., Lassus, M., Benedetti, M. S., Pianezzola, E., & Coombes, R. C. (1992) · PubMed · Cited by 161
Fotsis, T., & Adlercreutz, H. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90379-7 · Cited by 142
Dowsett, M., Cunningham, D., Stein, R. C., Evans, S., Dehennin, L., Hedley, A. J., & Coombes, R. C. (1989) · PubMed · Cited by 140
Self-citationARIMIDEX™: A new oral, once-a-day aromatase inhibitor
Plourde, P. V., Dyroff, M. C., Dowsett, M., et al. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00045-2 · Cited by 120
Self-citationLønning, P. E., Dowsett, M., & Powles, T. (1990) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(90)90241-j · Cited by 110
Self-citationMechanisms of Action of Aminoglutethimide as Endocrine Therapy of Breast Cancer
Lønning, P. E., & Kvinnsland, S. (1988) · Drugs · doi:10.2165/00003495-198835060-00005 · Cited by 101
Self-citationInhibition of Aromatase With CGS 16949A in Postmenopausal Women*
Santen, R. J., Demers, L. M., Adlercreutz, H., Harvey, H., Santner, S. J., Sanders, S. I., & Lipton, A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-99 · Cited by 99
MacNeill, F., Jones, A. L., Jacobs, S., Lønning, P. E., Powles, T., & Dowsett, M. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.339 · Cited by 94
Self-citationJones, A. L., MacNeill, F., Jacobs, S., Lønning, P. E., Dowsett, M., & Powles, T. J. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90074-c · Cited by 92
Self-citationDowsett, M., Stein, R. C., Mehta, A., & Coombes, R. C. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00906.x · Cited by 85
Self-citationDemers, L. M., Lipton, A., Harvey, H. A., Kambic, K. B., Grossberg, H., Brady, C., & Santen, R. J. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90283-3 · Cited by 83
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women
Iveson, T. J. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.324 · Cited by 82
The influence of CGS 16949A on peripheral aromatisation in breast cancer patients
Lønning, P. E., Jacobs, S., Jones, A. L., Haynes, B. P., Powles, T., & Dowsett, M. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.175 · Cited by 82
Self-citationLønning, P. E., Helle, S. I., Johannessen, D. C., Adlercreutz, H., Lien, E. A., Tally, M., Ekse, D., Fotsis, T., Anker, G. B., & Hall, K. E. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02594.x · Cited by 72
Self-citationEFFECTS OF AMINOGLUTETHIMIDE ON ADRENAL STEROID SECRETION
Vermeulen, A., Paridaens, R., & Heuson, J.-C. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00044.x · Cited by 69
Reed, M. J., Lai, L. C., Owen, A. M., et al. (1990) · PubMed · Cited by 67
Lønning, P. E., & Ekse, D. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00180-8 · Cited by 51
Self-citationJacobs, S., Lønning, P. E., Haynes, B. P., Griggs, L., & Dowsett, M. (1991) · Journal of enzyme inhibition · doi:10.3109/14756369109030396 · Cited by 45
Self-citationvan der Wall, E., Donker, T. H., Frankrijker, E. D., et al. (1993) · PubMed · Cited by 42
Aromatase inhibitor development for treatment of breast cancer
Masamura, S., Adlercreutz, H., Harvey, H. A., Lipton, A., DEMERS, L. M., Santen, R. J., & Santner, S. J. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666067 · Cited by 37
Lipton (1995) · Pure Amsterdam UMC · doi:10.1002/1097-0142(19950415)75:8 · Cited by 1
Cited by
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,577
Nabholtz, J. M., Buzdar, A., Pollak, M., Harwin, W., Burton, G., Mangalik, A., Steinberg, M., Webster, A., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3758 · Cited by 992
Bonneterre, J., Thürlimann, B., Robertson, J. F. R., Krzakowski, M., Mauriac, L., Koralewski, P., Vergote, I., Webster, A., Steinberg, M., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3748 · Cited by 842
Geisler, J., Haynes, B., Anker, G., Dowsett, M., & Lønning, P. E. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.751 · Cited by 604
Self-citation
Metadata
- Authors
- Geisler, J., King, N., Dowsett, M., Ottestad, L., Lundgren, S., Walton, P., Kormeset, P., & Lønning, P.
- Venue
- British Journal of Cancer
- Published
- 1996-10
- Volume
- 74
- Issue
- 8
- Pages
- 1286-1291
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1994207027
- Cited by
- 336
- References
- 28
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.